| 1 |
33886066 | Author Correction to: Biotransformation of Ginsenoside Rb1 to Ginsenoside CK by Strain XD101: a Safe Bioconversion Strategy. | 2021 Sep |
1 |
| 2 |
34013944 | Ginsenoside CK induces apoptosis of human cervical cancer HeLa cells by regulating autophagy and endoplasmic reticulum stress. | 2021 Jun 21 |
1 |
| 3 |
34051328 | Ginsenoside CK inhibits obese insulin resistance by activating PPARγ to interfere with macrophage activation. | 2021 Aug |
2 |
| 4 |
30662298 | Ginsenoside compound K protects human umbilical vein endothelial cells against oxidized low-density lipoprotein-induced injury via inhibition of nuclear factor-κB, p38, and JNK MAPK pathways. | 2019 Jan |
2 |
| 5 |
25738334 | 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginsenoside Rb1, enhances the production of hyaluronic acid through the activation of ERK and Akt mediated by Src tyrosin kinase in human keratinocytes. | 2015 May |
1 |
| 6 |
25137374 | The ginsenoside 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol induces autophagy and apoptosis in human melanoma via AMPK/JNK phosphorylation. | 2014 |
1 |
| 7 |
22083988 | Ultra-performance liquid chromatography and time-of-flight mass spectrometry analysis of ginsenoside metabolites in human plasma. | 2011 |
1 |